Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes

被引：0
|
作者：
Hayashi, M [1 ]
Yatsushiro, S
Yamada, H
Yamamoto, A
Futai, M
Yamaguchi, A
Moriyama, Y
机构：
[1] Osaka Univ, ISIR, Dept Cell Membrane Biol, CREST,Japan Sci & Technol Corp, Ibaraki, Osaka 567, Japan
[2] Osaka Univ, ISIR, Dept Mol Cell Biol, CREST,Japan Sci & Technol Corp, Ibaraki, Osaka 567, Japan
[3] Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 570, Japan
来源：
MELATONIN AFTER FOUR DECADES: AN ASSESSMENT OF ITS POTENTIAL | 1999年 / 460卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：91 / 93
页数：3
相关论文
共 50 条
  • [21] The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae
    Madeo, Marianna
    Kovacs, Attila D.
    Pearce, David A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33066 - 33071
  • [22] Synaptic vesicle protein-2A(SV2A)regulates vesicular pool at sympathetic neuron synapses
    Tanifuji, Shota
    Vogl, Christian
    Stephens, Gary J.
    Mochida, Sumiko
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S188 - S188
  • [23] Negative Modulation of the Synaptic Vesicle Protein (SV2A): A New Pharmacological Target for Cognitive Deficit Associated with Schizophrenia
    Detrait, Eric R.
    Laruelle, Marc
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martyn
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 133S - 133S
  • [24] NEGATIVE MODULATION OF THE SYNAPTIC VESICLE PROTEIN (SV2A): A NEW PHARMACOLOGICAL TARGET FOR COGNITIVE DEFICIT ASSOCIATED WITH SCHIZOPHRENIA
    Laruelle, Marc
    Detrait, Eric
    Lamberty, Yves
    Leclercq, Karine
    Jnoff, Eric
    Wood, Martin
    Gillard, Michel
    Jigorel, Emilie
    Klitgaard, Henrik
    Provins, Laurent
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S66 - S66
  • [25] Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET
    Serrano, Maria Elisa
    Becker, Guillaume
    Bahri, Mohamed Ali
    Seret, Alain
    Mestdagh, Nathalie
    Mercier, Joel
    Mievis, Frederic
    Giacomelli, Fabrice
    Lemaire, Christian
    Salmon, Eric
    Luxen, Andre
    Plenevaux, Alain
    MOLECULES, 2019, 24 (09):
  • [26] Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
    Ohno, Yukihiro
    Tokudome, Kentaro
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 463 - 471
  • [27] SYNAPTIC VESICLE PROTEIN 2A (SV2A) EXPRESSION IN EPILEPSY-ASSOCIATED BRAIN TUMORS AND IN THE PERILESIONAL EPILEPTIC CORTEX
    Aronica, E.
    Toering, S.
    Boer, K.
    Heimans, J.
    Reijneveld, J.
    EPILEPSIA, 2009, 50 : 89 - 89
  • [28] Synaptic Vesicle Protein 2 (SV2) Isoforms
    Bandala, Cindy
    Miliar-Garcia, A.
    Mejia-Barradas, C. M.
    Anaya-Ruiz, M.
    Luna-Arias, J. P.
    Bazan-Mendez, C. I.
    Gomez-Lopez, M.
    Juarez-Mendez, S.
    Lara-Padilla, E.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5063 - 5067
  • [29] Distinct synaptic vesicle recycling in inhibitory nerve terminals is coordinated by SV2A
    Bae, Jae Ryul
    Lee, Wongyoung
    Jo, Young Ok
    Han, Sukmin
    Koh, Soulmee
    Song, Woo Keun
    Kim, Sung Hyun
    PROGRESS IN NEUROBIOLOGY, 2020, 194
  • [30] Enhanced dopaminergic neurotransmission in the nucleus accumbens by the gene mutation of synaptic vesicle protein 2A (SV2A)
    Tokudome, Kentaro
    Shimizu, Saki
    Kunisawa, Naofumi
    Hashimoto, Azuki
    Hiraoka, Yuki
    Fukuda, Kazuki
    Ikari, Ayako
    Iguchi, Yumiko
    Sugahara, Takafumi
    Mashimo, Tomoji
    Serikawa, Tadao
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S152 - S152
12345